Hospira Recalls Propofol Injectable Vials Due to Particulate Matter
Hospira Inc. is recalling 245,250 vials of Propofol Injectable Emulsion because a single visible particulate was found during a retain sample inspection.
- Product
- PROPOFOL — PROPOFOL (PROPOFOL)
- Category
- Drug
- Distribution
- Distributed nationwide